Graham Medical, a manufacturer and marketer of products for the healthcare industry, has introduced a pediatric line of its successful InhibX antimicrobial-treated paper products. The pediatric-sized table paper and gowns, printed with the germ-fighting superhero Captain InhibX and treated with an antimicrobial agent, provide an added layer of protection against cross-contamination in pediatricians offices.
"We are pleased to extend our successful InhibX antimicrobial products to include the care of children," says Brian Segrin, vice president and general manager of Graham Medical. "The InhibX products not only help resist cross-contamination, but the child-friendly Captain InhibX design also reinforces to parents that the pediatricians office is taking every precaution to protect their patients from germs."
The pediatric table paper and gowns feature a free set of Captain InhibX temporary tattoos in every case for a limited time, providing another opportunity for caregivers to reinforce other germ-prevention techniques with kids like proper handwashing. The products are the latest iteration of Graham Medicals successful InhibX line of antimicrobial paper products that include adult-sized table paper, towels, drapes and gowns.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.